Asan Medical Center, University of Ulsan College of Medicine
Asan Medical Center, University of Ulsan College of Medicine
Seoul, South Korea4 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Trial of Low-intensity Anticoagulation to Reduce GI or Other Bleeding Complications With Equivalent Therapeutic Efficacy in HeartMate 3 LVAD Patients | Digestive System Diseases, Embolism and Thrombosis, Gastrointestinal Hemorrhage, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Thromboembolism, advanced heart failure, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, digestive system disorder, nervous system disorder, stroke disorder, vascular disorder | Not yet recruiting | Phase 4 | 2025-07-23 | NCT07081035 | |
| A Prospective Randomized Comparison of HDAC Vs AD in the Induction Chemothrapy for AML. | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Enrolling by invitation | Phase 3 | 2025-03-17 | NCT03507842 | |
| CyFluATG in Lower Risk MDS | Hemic and Lymphatic Diseases, bone marrow disorder, hematologic disorder, myelodysplastic syndrome | Active, not recruiting | Phase 2 | 2023-10-24 | NCT06098326 | |
| HCT With PTCy in Higher-risk MDS | Chronic Disease, Disease Attributes, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, acute myeloid leukemia, bone marrow disorder, chronic myelomonocytic leukemia, hematologic disorder, leukemia, myelodysplastic/myeloproliferative disease, myeloid leukemia, neoplasm | Active, not recruiting | Phase 2 | 2023-10-24 | NCT06098313 |